Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study
Open Access
- 5 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2) , e55712
Abstract
Genetic association studies have revealed numerous polymorphisms conferring susceptibility to melanoma. We aimed to replicate previously discovered melanoma-associated single-nucleotide polymorphisms (SNPs) in a Greek case-control population, and examine their predictive value. Based on a field synopsis of genetic variants of melanoma (MelGene), we genotyped 284 patients and 284 controls at 34 melanoma-associated SNPs of which 19 derived from GWAS. We tested each one of the 33 SNPs passing quality control for association with melanoma both with and without accounting for the presence of well-established phenotypic risk factors. We compared the risk allele frequencies between the Greek population and the HapMap CEU sample. Finally, we evaluated the predictive ability of the replicated SNPs. Risk allele frequencies were significantly lower compared to the HapMap CEU for eight SNPs (rs16891982 – SLC45A2, rs12203592 – IRF4, rs258322 – CDK10, rs1805007 – MC1R, rs1805008 - MC1R, rs910873 - PIGU, rs17305573- PIGU, and rs1885120 - MTAP) and higher for one SNP (rs6001027 – PLA2G6) indicating a different profile of genetic susceptibility in the studied population. Previously identified effect estimates modestly correlated with those found in our population (r = 0.72, PCLPTM1L (odds ratio [OR] 1.60, 95% CI 1.22–2.10; P = 0.001), rs16891982-C in SCL45A2 (OR 0.51, 95% CI 0.34–0.76; P = 0.001), and rs1805007-T in MC1R (OR 4.38, 95% CI 2.03–9.43; P = 2×10−5). Nominally statistically significant associations were seen also for another 5 variants (rs258322-T in CDK10, rs1805005-T in MC1R, rs1885120-C in MYH7B, rs2218220-T in MTAP and rs4911442-G in the ASIP region). The addition of all SNPs with nominal significance to a clinical non-genetic model did not substantially improve melanoma risk prediction (AUC for clinical model 83.3% versus 83.9%, p = 0.66). Overall, our study has validated genetic variants that are likely to contribute to melanoma susceptibility in the Greek population.Keywords
This publication has 51 references indexed in Scilit:
- MC1R, ASIP, and DNA Repair in Sporadic and Familial Melanoma in a Mediterranean PopulationJNCI: Journal of the National Cancer Institute, 2005
- Epidemiological differences for cutaneous melanoma in a relatively dark-skinned caucasian population with chronic sun exposureEuropean Journal of Cancer, 2004
- Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposureJournal of Medical Genetics, 2004
- Quantitative Measures of the Effect of the Melanocortin 1 Receptor on Human Pigmentary Status11Presented in part at ESDR Geneva 2002, Naysmith L, Ha T, Waterston K, et al: Melanocortin 1 receptor accounts for 50% of variation in a Northern European dataset. J Invest Dermatol 119:758, 2002 (abstr).Journal of Investigative Dermatology, 2004
- Interactive effects of MC1R and OCA2 on melanoma risk phenotypesHuman Molecular Genetics, 2003
- Genetic epidemiology of melanomaEuropean Journal of Cancer, 2003
- Melanoma etiology: where are we?Oncogene, 2003
- Melanocortin 1 Receptor (MC1R) Gene Variants are Associated with an Increased Risk for Cutaneous Melanoma Which is Largely Independent of Skin Type and Hair ColorJournal of Investigative Dermatology, 2001
- Melanocortin-1 Receptor Gene Variants Determine the Risk of Nonmelanoma Skin Cancer Independently of Fair Skin and Red HairThe American Journal of Human Genetics, 2001
- Counseling and DNA Testing for Individuals Perceived to Be Genetically Predisposed to Melanoma: A Consensus Statement of the Melanoma Genetics ConsortiumJournal of Clinical Oncology, 1999